Yıl: 2015 Cilt: 9 Sayı: 2 Sayfa Aralığı: 147 - 151 Metin Dili: Türkçe İndeks Tarihi: 29-07-2022

Karbamazepine bağlı dress sendromu; Nadir görülen bir ilaç hipersensitivite reaksiyonu

Öz:
DRESS (Drug Reaction with Eosinophilia and Systemic Symptoms) sendromu, ateş, deri döküntüsü, lenfadenopati veiç organ tutulumuyla karakterize, yaşamı tehdit edebilen ve çocukluk çağında nadir görülen bir gecikmiş tip ilaç hiper-sensitivite reaksiyonudur.Beş yaşında kız hasta, epilepsi tanısı ile karbamazepin tedavisi başlandıktan bir ay sonra, vücudunda yaygın döküntüve ateş yakınmalarıyla başvurdu. Fizik muayenede ateş, deride yaygın makülopapüler döküntü, submandibular bölgedebilateral lenfadenopati ve hepatomegali mevcuttu.Hastaya klinik bulgular ve laboratuvar incelemeleri (atipik lenfositlerin varlığı, eozinofli ve hipertransaminazemi) sonucun -da DRESS sendromu tanısı konuldu ve destek tedavisi, sistemik kortikosteroid ve intravenöz immünglobulin (İVİG) iletedavi edildi.İlaç kullanma öyküsü, ateş, deri döküntüsü, lenfadenopati ve iç organ tutulumu bulguları olan çocuklarda ayırıcı tanıdaDRESS sendromu göz önünde tutulmalıdır. Tedavide temel prensipler, hastalığa erken tanı konulması, neden olduğudüşünülen ilacın kesilmesi ve destek tedavisidir. Özellikle ciddi olgularda sistemik kortikosteroid ve İVİG tedavisi kullanıl -ması önerilmektedir.
Anahtar Kelime:

Konular: Alerji Pediatri

Carbamazepine-related dress syndrome; A rarely seen drug hypersensitivity reaction

Öz:
The DRESS (Drug Reaction with Eosinophilia and Systemic Symptoms) syndrome, characterized by fever, skin rash,lymphadenopathy and internal organ involvement is a delayed-type drug-hypersensitivity reaction that is life-threateningand rarely seen in childhood.A fve-year-old girl was admitted with complaints of extensive rash and fever a month after the onset of treatment withcarbamazepine for a diagnosis of epilepsy. Physical examination revealed fever, an extensive maculopapular rash,submandibular lymphadenopathy and hepatomegaly.The patient was diagnosed with the DRESS syndrome as a result of the clinical and laboratory fndings (presenceof atypical lymphocytes, eosinophilia and hypertransaminasemia) and treated supportively together with systemiccorticosteroids and intravenous immunoglobulin (IVIG).The DRESS syndrome should be considered in the differential diagnosis in children with a history of drug use presentingwith fever, skin rash, lymphadenopathy and internal organ involvement. The basic principles in the treatment includeearly diagnosis, termination of suspected drugs and supportive therapy. Systemic corticosteroids and IVIG therapy arerecommended, especially in severe cases.
Anahtar Kelime:

Konular: Alerji Pediatri
Belge Türü: Makale Makale Türü: Olgu Sunumu Erişim Türü: Erişime Açık
  • 1. Cacoub P, Musette P, Descamps V. The DRESS syndrome: A literature review. Am J Med 2011;124:588-97.
  • 2. Husain Z, Reddy BY, Schwartz RA. DRESS syndrome, Part I: Clinical perspectives. J Am Acad Dermatol 2013;68:693-705.
  • 3. Kardaun SH, Sidoroff A, Valeyrie-Allanore L, Halevy S, Davidovici BB, Mockenhaupt M, et al. Variability in the clinical pattern of cutaneous side-effects of drugs with systemic symptoms: Does a DRESS syndrome really exist? Br J Dermatol 2007;156:609-11.
  • 4. Knowles SR, Dewhurst N, Shear NH. Anticonvulsant hypersensiti - vity syndrome: An update. Expert Opin Drug Saf 2012;11:767-78.
  • 5. Bocquet H, Bagot M, Roujeau JC. Drug-induced pseudolymphoma and drug hypersensitivity syndrome (Drug Rash With Eosinophilia and Systemic Symptoms: DRESS). Semin Cutan Med Surg 1996;15:250-7.
  • 6. Criado PR, Avancini J, Santi CG, Medrado AT, Rodrigues CE, de Carvalho JF. Drug reaction with eosinophilia and systemic symptoms (DRESS): A complex interaction of drugs, viruses and the immune system. Isr Med Assoc J 2012;14:577-82.
  • 7. Li L-F, Ma C. Epidemiological study of severe cutaneous adverse drug reactions in a city district of China. Clin Exp Dermatol 2006;31:642-7.
  • 8. Kardaun SH, Sekula P, Valeyrie-Allanore L, Liss Y, Chu CY, Creamer D, et al. RegiSCAR study group. Drug reaction with eosinophilia and systemic symptoms (DRESS): An original multisystem adverse drug reaction. Results from the prospective RegiSCAR study. Br J Dermatol 2013;169:1071-80.
  • 9. Tennis P, Stern RS. Risk of serious cutaneous disorders after initiation of use of phenytoin, carbamazepine, or sodium valproate: a record linkage study. Neurology 1997;49:542-6.
  • 10. Newell BD, Moinfar M, Mancini AJ, Nopper AJ. Retrospective analysis of 32 pediatric patients with anticonvulsant hypersensitivity syndrome (ACHSS). Pediatr Dermatol 2009;26:536-46.
  • 11. Peyrière H, Dereure O, Breton H, Demoly P, Cociglio M, Blayac JP, et al. Network of the French Pharmacovigilance Centers. Variability in the clinical pattern of cutaneous side effects of drugs with systemic symptoms: Does a DRESS syndrome really exist? Br J Dermatol 2006;155:422-8.
  • 12. Irga N, Kosiak W, Jaworski R, Zielinski J, Adamkiewicz-Drozynska E. Pediatrician! Do you know the symptoms of DRESS syndrome? A case report of a 4-year-old girl. Pediatr Emer Care 2013;29: 504-7.
  • 13. Fiszenson-Albala F, Auzerie V, Mahe E, Farinotti R, Durand-Stocco C, Crickx B, et al. A 6-month prospective survey of cutaneous drug reactions in a hospital setting. Br J Dermatol 2003;149:1018-22.
  • 14. Oskay T, Karademir A, Erturk OI. Association of anticonvulsant hypersensitivity syndrome with Herpesvirus 6, 7. Epilepsy Res 2006;70:27-40.
  • 15. Tohyama M, Hashimoto K, Yasukawa M, Kimura H, Horikawa T, Nakajima K, et al. Association of humanherpesvirus 6 reactivation with the faring and severity of drug induced hypersensitivity syndrome. Br J Dermatol 2007;157:934-40.
  • 16. Walsh S, Diaz-Cano S, Higgins E, Morris-Jones R, Bashir S, Bernal W, et al. Drug reaction with eosinophilia and systemic symptoms: Is cutaneous phenotype a prognostic marker for outcome? A review of clinicopathological features of 27 cases. Br J Dermatol 2013;168:391-401.
  • 17. Descamps V, Ben-Saïd B, Sassolas B, Truchetet F, Avenel-Audran M, Girardin P, et al. Groupe Toxidermies de la Société Française de Dermatologie: Management of drug reaction with eosinophilia and systemic symptoms (DRESS). Ann Dermatol Venereol 2010;137:703-8.
  • 18. Prais D, Straussberg R, Amir J, Nussinovitch M, Harel L. Treatment of anticonvulsant hypersensitivity syndrome with intravenous immunoglobulins and corticosteroids. J Child Neurol 2006;2: 380-4.
  • 19. Moling O, Tappeiner L, Piccin A, Pagani E, Rossi P, Rimenti G, et al. Treatment of DIHS/DRESS syndrome with combined N-acetylcysteine, prednisone and valganciclovir-a hypothesis. Med Sci Monit 2012;18:57-62.
  • 20. Barbaud A, Collet E, Milpied B, Assier H, Staumont D, Avenel- Audran M, et al. Toxidermies Group of the French Society of Dermatology. A multicentre study to determine the value and safety of drug patch tests for the three main classes of severe cutaneous adverse drug reactions. Br J Dermatol 2013;168:555-62.
APA CANITEZ Y, EFE POYRAZ H, Sapan N (2015). Karbamazepine bağlı dress sendromu; Nadir görülen bir ilaç hipersensitivite reaksiyonu. , 147 - 151.
Chicago CANITEZ Yakup,EFE POYRAZ Hülya,Sapan Nihat Karbamazepine bağlı dress sendromu; Nadir görülen bir ilaç hipersensitivite reaksiyonu. (2015): 147 - 151.
MLA CANITEZ Yakup,EFE POYRAZ Hülya,Sapan Nihat Karbamazepine bağlı dress sendromu; Nadir görülen bir ilaç hipersensitivite reaksiyonu. , 2015, ss.147 - 151.
AMA CANITEZ Y,EFE POYRAZ H,Sapan N Karbamazepine bağlı dress sendromu; Nadir görülen bir ilaç hipersensitivite reaksiyonu. . 2015; 147 - 151.
Vancouver CANITEZ Y,EFE POYRAZ H,Sapan N Karbamazepine bağlı dress sendromu; Nadir görülen bir ilaç hipersensitivite reaksiyonu. . 2015; 147 - 151.
IEEE CANITEZ Y,EFE POYRAZ H,Sapan N "Karbamazepine bağlı dress sendromu; Nadir görülen bir ilaç hipersensitivite reaksiyonu." , ss.147 - 151, 2015.
ISNAD CANITEZ, Yakup vd. "Karbamazepine bağlı dress sendromu; Nadir görülen bir ilaç hipersensitivite reaksiyonu". (2015), 147-151.
APA CANITEZ Y, EFE POYRAZ H, Sapan N (2015). Karbamazepine bağlı dress sendromu; Nadir görülen bir ilaç hipersensitivite reaksiyonu. Türkiye Çocuk Hastalıkları Dergisi, 9(2), 147 - 151.
Chicago CANITEZ Yakup,EFE POYRAZ Hülya,Sapan Nihat Karbamazepine bağlı dress sendromu; Nadir görülen bir ilaç hipersensitivite reaksiyonu. Türkiye Çocuk Hastalıkları Dergisi 9, no.2 (2015): 147 - 151.
MLA CANITEZ Yakup,EFE POYRAZ Hülya,Sapan Nihat Karbamazepine bağlı dress sendromu; Nadir görülen bir ilaç hipersensitivite reaksiyonu. Türkiye Çocuk Hastalıkları Dergisi, vol.9, no.2, 2015, ss.147 - 151.
AMA CANITEZ Y,EFE POYRAZ H,Sapan N Karbamazepine bağlı dress sendromu; Nadir görülen bir ilaç hipersensitivite reaksiyonu. Türkiye Çocuk Hastalıkları Dergisi. 2015; 9(2): 147 - 151.
Vancouver CANITEZ Y,EFE POYRAZ H,Sapan N Karbamazepine bağlı dress sendromu; Nadir görülen bir ilaç hipersensitivite reaksiyonu. Türkiye Çocuk Hastalıkları Dergisi. 2015; 9(2): 147 - 151.
IEEE CANITEZ Y,EFE POYRAZ H,Sapan N "Karbamazepine bağlı dress sendromu; Nadir görülen bir ilaç hipersensitivite reaksiyonu." Türkiye Çocuk Hastalıkları Dergisi, 9, ss.147 - 151, 2015.
ISNAD CANITEZ, Yakup vd. "Karbamazepine bağlı dress sendromu; Nadir görülen bir ilaç hipersensitivite reaksiyonu". Türkiye Çocuk Hastalıkları Dergisi 9/2 (2015), 147-151.